false
0001898766
0001898766
2026-03-30
2026-03-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 30, 2026
Trio
Petroleum Corp
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-41643 |
|
87-1968201 |
(State
or other Jurisdiction
of
Incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
23823
Malibu Road, Suite 304
Malibu,
CA 90265
(661)
324-3911
(Address
and telephone number, including area code, of registrant’s principal executive offices)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:.
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.0001 per share |
|
TPET |
|
The
NYSE American |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
8.01. Other Events.
On
January 9, 2026, Trio Petroleum Corp, a Delaware corporation (the “Company”), filed a Current Report on Form 8-K (the “January
9th 8-K”) with the Securities and Exchange Commission (the “Commission”) reporting that it had entered into
an At Market Issuance Sales Agreement (the “ATM Agreement”) with Ladenburg Thalmann & Co. Inc. as agent (the “Sales
Agent”) pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share (“Common
Stock”), from time to time through the Sales Agent (the “Offering”). On January 9, 2026, the Company also filed a prospectus
supplement with the Commission covering the sale of shares of Common Stock having an aggregate offering price of up to $3,600,000, in
connection with the Offering (the “Prospectus Supplement”), along with the base prospectus (the “Base Prospectus”),
under its existing Registration Statement on Form S-3 (File No 333-281813), which became effective on September 10, 2024 (the “Registration
Statement”).
On
March 3, 2026, the Company filed Amendment No. 1 to the Prospectus Supplement (“Amendment No. 1”) amending and supplementing
the Prospectus Supplement to update the amount of shares eligible for sale under General Instruction I.B.6 of Form S-3 (“Instruction
I.B.6.). Following the filing of Amendment No. 1, the aggregate amount of shares that were available for sale was $3,292,000. The maximum
aggregate offering amount was $6,892,000, which included shares of Common Stock having an aggregate sales price of $3,599,885 (7,344,372
shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement.
On
March 4, 2026, the Company filed Amendment No. 2 to the Prospectus Supplement (“Amendment No. 2”) further amending and supplementing
the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following
the filing of Amendment No. 2, the aggregate amount of shares that were available for sale was $6,485,000. The maximum aggregate offering
amount was $13,377,000, which included shares of Common Stock having an aggregate sales price of $6,891,859 (9,254,648 shares of Common
Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.
On
March 5, 2026, the Company filed Amendment No. 3 to the Prospectus Supplement (“Amendment No. 3”) further amending and supplementing
the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following
the filing of Amendment No. 3, the aggregate amount of shares that were available for sale was $4,000,000. The maximum aggregate offering
amount was $17,377,000, which included shares of Common Stock having an aggregate sales price of $13,376,774 (15,348,345 shares of Common
Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.
On
March 10, 2026, the Company filed Amendment No. 4 to the Prospectus Supplement (“Amendment No. 4”) further amending and supplementing
the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following
the filing of Amendment No. 4, the aggregate amount of shares that were available for sale was
$1,641,000 (the “Placement Shares”). The maximum
aggregate offering amount was $19,018,000, which included shares
of Common Stock having an aggregate sales price of $17,375,884 (18,139,045 shares of Common Stock) that were previously sold pursuant
to the Prospectus Supplement, as amended.
On
March 30, 2026, the Company filed Amendment No. 5 to the Prospectus Supplement (“Amendment No. 5”) further amending and supplementing
the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following
the filing of Amendment No. 5, the aggregate amount of shares that are available for sale is $1,010,000 (the “Placement Shares”).
The maximum aggregate offering amount is $20,028,000, which includes shares of Common Stock having an aggregate sales price of $19,016,726
(19,202,455 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.
All
other terms of the Offering and the ATM Agreement are described in the January 9th 8-K and the ATM Agreement, which is filed
as Exhibit 10.1 to the January 9th 8-K.
The
legal opinion of Ellenoff Grossman & Schole LLP, counsel to the Company, relating to the Placement Shares being offered is filed
as Exhibit 5.1 to this Current Report on Form 8-K.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
| Exhibit
No. |
|
Description |
| 5.1 |
|
Opinion of Ellenoff Grossman & Schole LLP |
| 10.1* |
|
At Market Issuance Sales Agreement, dated January 9, 2026, between the Trio Petroleum Corp and Ladenburg Thalmann Co. Inc. |
| 23.1 |
|
Consent of Ellenoff Grossman & Schole LLP (included in Exhibit 5.1) |
| 104 |
|
Cover
Page Interactive Data File (embedded within the XBRL document) |
*
Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the Commission on January 9, 2026
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Dated:
March 30, 2026 |
|
| |
|
| Trio
Petroleum Corp. |
|
| |
|
|
| By: |
/s/
Robin Ross |
|
| Name: |
Robin
Ross |
|
| Title: |
Chief
Executive Officer |
|
